BlackRock
ESLA icon

BlackRock’s Estrella Immunopharma ESLA Stock Holding History

BlackRock’s Portfolio ESLA Stock Details ESLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.1K Buy
52,033
+12,143
+30% +$15.9K ﹤0.01% 5155
2026
Q1 		$42.3K Buy
39,890
+13,420
+51% +$15.4K ﹤0.01% 5165
2025
Q4 		$41.3K Buy
26,470
+2,386
+10% +$4.52K ﹤0.01% 5092
2025
Q3 		$27.7K Sell
24,084
-7,323
-23% -$7.03K ﹤0.01% 5090
2025
Q2 		$30.2K Buy
31,407
+6,754
+27% +$6.55K ﹤0.01% 5078
2025
Q1 		$22.9K Sell
24,653
-465
-2% -$512 ﹤0.01% 5074
2024
Q4 		$30.1K Buy
25,118
+155
+0.6% +$156 ﹤0.01% 5042
2024
Q3 		$29K Buy
24,963
+17,395
+230% +$22.4K ﹤0.01% 4896
2024
Q2 		$7.95K Buy
+7,568
New +$7.74K ﹤0.01% 5090

Other funds holding ESLA

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock's ESLA Position: Q2 2026 in Review

BlackRock increased its Estrella Immunopharma (ESLA) stake by 30% in Q2 2026, buying an estimated $15.9K and bringing the position to 52,033 shares worth $54.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5155.

BlackRock first reported a position in ESLA in Q2 2024 and has held it in 9 quarters since. 15 funds tracked by Wall St. Rank hold ESLA as of Q2 2026.

  • BlackRock held 52,033 shares of Estrella Immunopharma worth $54.1K as of Q2 2026.
  • BlackRock bought 12,143 Estrella Immunopharma shares in Q2 2026, an estimated $15.9K.
  • Estrella Immunopharma made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5155 holding.
  • BlackRock first reported a position in Estrella Immunopharma in Q2 2024 and has held it in 9 quarters since.
  • 15 funds tracked by Wall St. Rank held Estrella Immunopharma as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.